GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanopharmaceutics Inc (OTCPK:TGRP) » Definitions » Issuance of Stock

Nanopharmaceutics (Nanopharmaceutics) Issuance of Stock : $0.00 Mil (TTM As of Sep. 2018)


View and export this data going back to 2016. Start your Free Trial

What is Nanopharmaceutics Issuance of Stock?

Nanopharmaceutics's Issuance of Stock for the three months ended in Sep. 2018 was $0.00 Mil.

Nanopharmaceutics's Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2018 was $0.00 Mil.


Nanopharmaceutics Issuance of Stock Historical Data

The historical data trend for Nanopharmaceutics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanopharmaceutics Issuance of Stock Chart

Nanopharmaceutics Annual Data
Trend Dec15 Dec16 Dec17
Issuance of Stock
- - -

Nanopharmaceutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanopharmaceutics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanopharmaceutics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Nanopharmaceutics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanopharmaceutics (Nanopharmaceutics) Business Description

Traded in Other Exchanges
N/A
Address
14120 NW 126 Terrace, Alachua, FL, USA, 32615
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.